Medical and health researchers

Kanta Subbarao

Kanta Subbarao is a virologist and pediatric infectious diseases physician who directed the WHO Collaborating Centre for Reference and Research on Influenza in Melbourne from 2016 to 2024.

Kanu Chatterjee

Kanu Chatterjee, full name Kamalendu Chatterjee, was a Bangladeshi-born cardiologist who helped develop vasodilator therapy for heart failure and led coronary care at Cedars-Sinai and UCSF.

Karel Frederik Wenckebach (1864–1940) was a Dutch cardiologist who held chairs at Groningen, Strasbourg, and Vienna, described partial heart block in 1899, and pioneered quinidine for atrial fibrillation.

Karel Styblo

Karel Styblo, a physician who survived tuberculosis in a Nazi concentration camp, built the TB control model that WHO adopted as DOTS in the 1990s.

Karen A. Gelmon

Karen A. Gelmon is a Canadian medical oncologist and clinician-scientist known for breast cancer research and clinical trials of new cancer therapies, based at BC Cancer in Vancouver.

Karen Canfell

Karen Canfell is an Australian cancer epidemiologist and University of Sydney professor whose modeling underpinned Australia's 2017 HPV screening shift and the WHO cervical cancer elimination strategy.

Karen Cichowski

Karen Cichowski is an American cancer biologist and Harvard Medical School professor of medicine who studies how Ras signaling and the NF1 tumor suppressor drive cancer.

Sep 17, 2026

Karen Davis (health economist)

Karen Davis is an American health economist, professor emerita at the Johns Hopkins Bloomberg School of Public Health and former president of The Commonwealth Fund.

Karen Duff

Karen Duff is a neuroscientist studying Alzheimer's disease and tauopathies who directs the UK Dementia Research Institute at University College London and created key transgenic mouse models.

Karen E. Joynt Maddox

Karen E. Joynt Maddox is an American cardiologist and health services researcher at Washington University in St. Louis, known for large-scale evaluations of Medicare's Bundled Payments programs.

Karen H. Antman

Karen H. Antman is an American oncologist and hematologist known for the MAID regimen for advanced sarcoma, who served as Dean of Boston University's medical school from 2005 to 2024.

Karen H. Lu

Karen H. Lu is an American gynecologic oncologist and physician in chief at Moffitt Cancer Center in Tampa, Florida, known for research on hereditary ovarian and endometrial cancers.

Karen H. Vousden

Karen H. Vousden is a British cancer researcher known for her work on the p53 tumor suppressor and MDM2, and director of the CRUK Beatson Institute in Glasgow.

Karen Sliwa

Karen Sliwa is a German-born South African cardiologist who directs the Cape Heart Institute at the University of Cape Town and is known for research on peripartum cardiomyopathy.

Kari Alitalo

Kari Alitalo, born in 1952, is a Finnish physician-scientist at the University of Helsinki who discovered the VEGF-C/VEGFR-3 signaling pathway, key to lymphatic vessel growth and cancer metastasis research.

Kari Hemminki

Kari Hemminki, born 1947, is a Finnish cancer epidemiologist and geneticist who built the Swedish Family-Cancer Database and led cancer epidemiology at the German Cancer Research Center in Heidelberg.

Karim Fizazi

Karim Fizazi is a French medical oncologist specializing in prostate and genitourinary cancers, a professor at Paris-Saclay University who led landmark trials including LATITUDE, ARAMIS, and PEACE-1.

Karin B. Michels

Karin B. Michels is an epidemiologist working in epigenetic, nutritional, and cancer epidemiology, described as a co-founder of epigenetic epidemiology and chair of epidemiology at UCLA from 2016.

Karin B. Nelson

Karin B. Nelson is an American pediatric neurologist and neuroepidemiologist, a Scientist Emeritus at NINDS in Bethesda, Maryland, known for her 1986 study of cerebral palsy antecedents and a practice-changing phenobarbital trial.

Karine Clément

Karine Clément, born 1966, is a French physician-scientist and professor of nutrition at Pitié-Salpêtrière Hospital and Sorbonne Université, known for work on the genetics of obesity and adipose tissue biology.

Karl Engelman

Karl Engelman was an American physician-scientist in clinical pharmacology and hypertension, known for his 1967 study showing para-chlorophenylalanine inhibits serotonin synthesis in carcinoid syndrome, and for pheochromocytoma drug tests.

Karl G. Nicholson

Karl G. Nicholson, also published as Karl Nicholson, is a British physician-scientist, Professor of Infectious Diseases at the University of Leicester, known for influenza antiviral and vaccine trials.

Karl Gottfried Paul Döhle

Karl Gottfried Paul Döhle (1855–1928) was a German pathologist and bacteriologist at the University of Kiel who described Döhle bodies in 1911 and gave his name to Heller–Döhle aortitis.

Sep 17, 2026

Karl H. Beyer Jr.

Karl H. Beyer Jr. (1914–1996) was an American pharmacologist who led the Merck Sharp & Dohme team that discovered probenecid and the thiazide diuretics, winning the 1974 Lasker Award.

Karl H. Weisgraber

Karl H. Weisgraber is a lipoprotein biochemist who defined the structure-function relationships of apolipoprotein E, whose E4 form is a major genetic risk factor for Alzheimer's disease.

Karl Henry Beyer, Jr.

Karl Henry Beyer, Jr. (1914–1996) was an American pharmacologist who led the discovery of probenecid and the thiazide diuretics, including chlorothiazide, and won the Albert Lasker Award in 1974.

Karl Kleist

Karl Kleist (1879–1960) was a German psychiatrist, neurologist, and neuroanatomist, professor at Frankfurt from 1920, who first described several apraxias and founded the Wernicke–Kleist–Leonhard classification of endogenous psychoses.

Sep 17, 2026

Karl Landsteiner

Karl Landsteiner (1868–1943), Austrian-born physician and immunologist, discovered the ABO blood groups in 1900–1901 and the Rh factor with Wiener, enabling safe blood transfusion; Nobel Prize in Physiology or Medicine 1930, Rockefeller Institute.

Karl Lenggenhager

Karl Lenggenhager (1903–1989) was a Swiss surgeon, full professor, and director of the Surgical University Clinic at the Inselspital in Bern from 1942 to 1971, known for introducing low-dose heparin prophylaxis against postoperative thrombosis in 1935.